# Mondelez International, Inc.: overview

MDLZ · Nasdaq · CIK 1103982 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdlz.md) · [Financials](/companies/mdlz/financials.md) · [Filings](/companies/mdlz/filings.md) · [Insiders](/companies/mdlz/insiders.md)

Latest reported revenue: [$9.97bn](/filings/0001628280-26-068256.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-068256).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.6 d](/filings/0001628280-26-005345.md) | [9.3](/filings/0001628280-26-027937.md) | [9.0](/filings/0001628280-26-050179.md) | [9.7](/filings/0001628280-26-068256.md) | [10.5 d](/filings/0001628280-26-005345.md) | [10.1](/filings/0001628280-26-027937.md) | [9.4](/filings/0001628280-26-050179.md) | [10.0](/filings/0001628280-26-068256.md) |
| Gross margin | % | [38.6% d](/filings/0001628280-26-005345.md) | [26.1%](/filings/0001628280-26-027937.md) | [32.7%](/filings/0001628280-26-050179.md) | [26.8%](/filings/0001628280-26-068256.md) | [28.2% d](/filings/0001628280-26-005345.md) | [27.8%](/filings/0001628280-26-027937.md) | [42.6%](/filings/0001628280-26-050179.md) | [39.4%](/filings/0001628280-26-068256.md) |
| Operating margin | % | [16.8% d](/filings/0001628280-26-005345.md) | [7.3%](/filings/0001628280-26-027937.md) | [13.0%](/filings/0001628280-26-050179.md) | [7.6%](/filings/0001628280-26-068256.md) | [9.1% d](/filings/0001628280-26-005345.md) | [8.0%](/filings/0001628280-26-027937.md) | [20.8%](/filings/0001628280-26-050179.md) | [17.6%](/filings/0001628280-26-068256.md) |
| Net margin | % | [18.2% d](/filings/0001628280-26-005345.md) | [4.3%](/filings/0001628280-26-027937.md) | [7.1%](/filings/0001628280-26-050179.md) | [7.6%](/filings/0001628280-26-068256.md) | [6.3% d](/filings/0001628280-26-005345.md) | [5.6%](/filings/0001628280-26-027937.md) | [16.5%](/filings/0001628280-26-050179.md) | [13.1%](/filings/0001628280-26-068256.md) |
| Diluted EPS | $ per share | not reported | [0.31](/filings/0001628280-26-027937.md) | [0.49](/filings/0001628280-26-050179.md) | [0.57](/filings/0001628280-26-068256.md) | not reported | [0.44](/filings/0001628280-26-027937.md) | [1.20](/filings/0001628280-26-050179.md) | [1.02](/filings/0001628280-26-068256.md) |
| Free cash flow | $bn | [1.1 d](/filings/0001628280-26-005345.md) | [0.8](/filings/0001628280-26-027937.md) | [0.0 d](/filings/0001628280-26-050179.md) | [0.4 d](/filings/0001628280-26-068256.md) | [2.0 d](/filings/0001628280-26-005345.md) | [0.2](/filings/0001628280-26-027937.md) | [0.5 d](/filings/0001628280-26-050179.md) | [1.0 d](/filings/0001628280-26-068256.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [28.7](/filings/0001103982-24-000019.md) | [31.5](/filings/0001103982-25-000030.md) | [36.0](/filings/0001628280-26-005345.md) | [36.4](/filings/0001628280-26-005345.md) | [38.5](/filings/0001628280-26-005345.md) |
| Gross margin | % | [39.2%](/filings/0001103982-24-000019.md) | [35.9%](/filings/0001103982-25-000030.md) | [38.2%](/filings/0001628280-26-005345.md) | [39.1%](/filings/0001628280-26-005345.md) | [28.4%](/filings/0001628280-26-005345.md) |
| Operating margin | % | [16.2%](/filings/0001103982-24-000019.md) | [11.2%](/filings/0001103982-25-000030.md) | [15.3%](/filings/0001628280-26-005345.md) | [17.4%](/filings/0001628280-26-005345.md) | [9.2%](/filings/0001628280-26-005345.md) |
| Net margin | % | [15.0%](/filings/0001103982-24-000019.md) | [8.6%](/filings/0001103982-25-000030.md) | [13.8%](/filings/0001628280-26-005345.md) | [12.7%](/filings/0001628280-26-005345.md) | [6.4%](/filings/0001628280-26-005345.md) |
| Diluted EPS | $ per share | [3.04](/filings/0001103982-24-000019.md) | [1.96](/filings/0001103982-25-000030.md) | [3.62](/filings/0001628280-26-005345.md) | [3.42](/filings/0001628280-26-005345.md) | [1.89](/filings/0001628280-26-005345.md) |
| Free cash flow | $bn | [3.2](/filings/0001103982-24-000019.md) | [3.0](/filings/0001103982-25-000030.md) | [3.6](/filings/0001628280-26-005345.md) | [3.5](/filings/0001628280-26-005345.md) | [3.2](/filings/0001628280-26-005345.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mdlz/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.13bn | 105,969,321 |  | Added +35,406 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.85bn | 83,858,130 |  | Added +528,392 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $4.03bn | 69,663,227 |  | Added +1,359,061 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $3.65bn | 60,744,872 |  | Reduced −1,393,144 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.48bn | 59,579,607 |  | Reduced −2,204,070 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $2.93bn | 50,549,498 |  | Added +529,676 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $2.64bn | 45,649,259 |  | Added +26,645,506 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.97bn | 34,110,119 |  | Added +452,497 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.73bn | 30,090,399 |  | Added +223,217 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.25bn | 21,676,534 |  | Reduced −2,675,369 |

## Recent filings

[All 1,692 filings](/companies/mdlz/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:18 ET | [10-Q](/filings/0001628280-26-068256.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068256 |
| 2026-10-29 | 16:09 ET | [8-K](/filings/0001628280-26-068233.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-068233 |
| 2026-07-28 | 16:18 ET | [10-Q](/filings/0001628280-26-050179.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050179 |
| 2026-07-28 | 16:09 ET | [8-K](/filings/0001628280-26-050157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050157 |
| 2026-06-18 | 16:45 ET | [8-K](/filings/0001628280-26-044384.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-044384 |
| 2026-05-26 | 16:04 ET | [8-K](/filings/0001628280-26-038064.md) | 5.07 Shareholder vote results | 0001628280-26-038064 |
| 2026-04-28 | 16:15 ET | [10-Q](/filings/0001628280-26-027937.md) | Quarterly report, period 2026-03-31 | 0001628280-26-027937 |
| 2026-04-28 | 16:07 ET | [8-K](/filings/0001628280-26-027915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-027915 |
| 2026-04-03 | 16:07 ET | [DEF 14A](/filings/0001628280-26-023640.md) | Proxy statement, period 2026-05-20 | 0001628280-26-023640 |
| 2026-02-18 | 16:05 ET | [8-K](/filings/0001628280-26-009018.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-009018 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-005345.md), filed Feb 4, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1103982
- Tickers: MDLZ
- Exchange: Nasdaq
- SIC code: 2000 Food and Kindred Products
- State of incorporation: IL
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:12 ET. No prices; not investment advice.